Shares of Protagonist Therapeutics PTGX have gained nearly 7% over the past week. The upside came after the company announced ...
Johnson & Johnson’s Icotyde receives US FDA approval for first-line systemic treatment of plaque psoriasis with a targeted oral peptide: Spring House, Pennsylvania Friday, March ...
Newsable Asianet News on MSN
Assault case: Delhi HC stays proceedings against Bina Modi, Lalit Bhasin
The Delhi High Court has stayed trial court proceedings against Bina Modi and Lalit Bhasin, who were summoned in an assault ...
ICOTYDE is the first and only IL-23R targeted oral peptide that delivers complete skin clearance and a favorable safety profile in a once-daily pill Approval supported by four phase 3 studies that met ...
J&J wins FDA nod for Icotyde, a once-daily oral psoriasis pill, boosting its new drugs portfolio and challenging injectable treatments in a key market.
Pediatric patients with moderate to severe hidradenitits suppurativa may now receive secukinumab following new FDA approval for those aged 12 and up.
Johnson & Johnson introduces the first and only IL-23R targeted oral peptide that delivers complete skin clearance and favorable safety profile in a once-daily pill ICOTYDE ...
Cosentyx is the only IL-17A inhibitor approved for this population, and the first differentiated mechanism in nearly a ...
ORKA-001 EVERLAST-A 16-week data now expected in 2Q 2026 following rapid enrollment, with longer-term follow-up data expected in 2H ...
US FDA approves Novartis Cosentyx for paediatric patients aged 12+ with moderate to severe hidradenitis suppurativa: Basel Monday, March 16, 2026, 14:00 Hrs [IST] Novartis announc ...
Pearson plc (NYSE:PSO) is one of the Best Undervalued UK Stocks to Invest In. On February 27, Pearson plc (NYSE:PSO) released preliminary results for fiscal 2025. The company reported 4% growth in ...
The Okmulgee Sheriff's office confirms there have been two deaths related to the tornado in Beggs on Saturday morning.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results